Sensei Biotherapeutics, Inc. (SNSE) Tops Q3 EPS by 2c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.29), $0.02 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• UBS Upgrades Kingspan Group PLC (KSP:ID) to Buy